✦ LIBER ✦

Central nervous system (CNS) relapse in diffuse large B cell lymphoma (DLBCL): pre- and post-rituximab

✍ Scribed by W. M. Tai; J. Chung; P. L. Tang; Y. X. Koo; X. Hou; K. W. Tay; R. Quek; M. Tao; S. T. Lim

Publisher: Springer
Year: 2011
Tongue: English
Weight: 258 KB
Volume: 90
Category: Article
ISSN: 0939-5555
DOI: 10.1007/s00277-010-1150-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Secondary central nervous system (CNS) i

Secondary central nervous system (CNS) involvement in patients with diffuse large B-cell lymphoma: a therapeutic dilemma

✍ Seok Jin Kim; Sung Yong Oh; Jin Seok Kim; Hawk Kim; Gyeong-Won Lee; Jong Ho Won; 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 233 KB

Risk factors for poor treatment outcome

Risk factors for poor treatment outcome and central nervous system relapse in diffuse large B-cell lymphoma with bone marrow involvement

✍ Keun-Wook Lee; Jongyoun Yi; In Sil Choi; Jee Hyun Kim; Soo-Mee Bang; Dong-Wan Ki 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 443 KB

β2-microglobulin aberrations in diffuse

β2-microglobulin aberrations in diffuse large B-cell lymphoma of the testis and the central nervous system

✍ Ekaterina S. Jordanova; Sietske A. Riemersma; Katja Philippo; Ed Schuuring; Phil 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 233 KB

## Abstract Human leukocyte antigen (HLA) class I molecules are expressed on the surface of all nucleated cells and present antigenic peptides to cytotoxic T cells, thereby playing an important role in initiating the cellular anti‐tumor immune response. We previously reported that loss of HLA class

Intravenous methotrexate as central nerv

Intravenous methotrexate as central nervous system (CNS) prophylaxis is associated with a low risk of CNS recurrence in high-risk patients with diffuse large B-cell lymphoma

✍ Kacey O'Rourke; Kirk Morris; Glen A. Kennedy 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB 👁 1 views

Intravenous methotrexate as central nerv

Intravenous methotrexate as central nervous system (CNS) prophylaxis is associated with a low risk of CNS recurrence in high-risk patients with diffuse large B-cell lymphoma

✍ Jeremy S. Abramson; Matthew Hellmann; Jeffrey A. Barnes; Peter Hammerman; Christ 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 174 KB 👁 1 views

Reply to intravenous methotrexate as cen

Reply to intravenous methotrexate as central nervous system (CNS) prophylaxis is associated with a low risk of CNS recurrence in high-risk patients with diffuse large B-cell lymphoma

✍ Jeremy S. Abramson; Ephraim P. Hochberg 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB 👁 2 views

I read with great interest the article by Cooperberg and coworkers 1 studying survival rates in differently treated men with early prostate cancer. In this study, patients who underwent radical prostatectomy had a substantially decreased disease-specific mortality, particularly in the higher-risk gr